Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Emory University
Endeavor Biomedicines, Inc.
Emory University
Memorial Sloan Kettering Cancer Center
Polaris Group
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Children's Oncology Group
Yale University
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)